Literature DB >> 7858102

The study of anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with systemic lupus erythematosus and central nervous system involvement.

T S Yeh1, C R Wang, G W Jeng, G L Lee, M Y Chen, G R Wang, K T Lin, C Y Chuang, C Y Chen.   

Abstract

Anticardiolipin (ACL) antibodies and interleukin-6 (IL-6) in cerebrospinal fluid (CSF) may be involved in the mechanism of lupus patients with central nervous system (CNS) involvement. ACL antibodies of 3 isotypes and IL-6 were measured in paired CSF and serum samples from 14 lupus patients with CNS involvement, 5 lupus patients without CNS involvement and 7 patients with non-inflammatory neurological diseases. ACL antibodies, IgG and IgM isotypes, and IL-6 were significantly increased in CSF from lupus patients with CNS involvement as compared with other 2 groups of patients. Both ACL antibodies and IL-6 decreased after neurological activity subsided. These results suggest increased ACL antibodies and IL-6 in CSF are involved in immune responses within CNS in lupus patients. Quantitation of CSF ACL antibodies may be helpful in evaluating neurological activity of lupus patients with CNS involvement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858102     DOI: 10.3109/08916939409007993

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  4 in total

Review 1.  Physiological and pathological roles of interleukin-6 in the central nervous system.

Authors:  D L Gruol; T E Nelson
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

2.  The study of circulating CD5 positive B lymphocytes in Chinese patients with rheumatoid arthritis.

Authors:  S T Liu; C R Wang; M F Liu; J S Li; H Y Lei; C Y Chuang
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

3.  Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.

Authors:  Estelle Trysberg; Kaj Blennow; Olof Zachrisson; Andrej Tarkowski
Journal:  Arthritis Res Ther       Date:  2004-09-23       Impact factor: 5.156

4.  Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus.

Authors:  Estelle Trysberg; Kina Höglund; Elisabet Svenungsson; Kaj Blennow; Andrej Tarkowski
Journal:  Arthritis Res Ther       Date:  2004-01-22       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.